VCM
Valiant Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-228,983
| Closed | -$12.9M | – | 26 |
|
|
2023
Q2 | $12.9M | Hold |
228,983
| – | – | 1.21% | 19 |
|
|
2023
Q1 | $10.4M | Hold |
228,983
| – | – | 0.82% | 19 |
|
|
2022
Q4 | $9.31M | Buy |
228,983
+38,800
| +20% | +$1.58M | 1.43% | 14 |
|
|
2022
Q3 | $12.4M | Sell |
190,183
-133,600
| -41% | -$8.73M | 1.24% | 19 |
|
|
2022
Q2 | $19.7M | Buy |
323,783
+83,100
| +35% | +$5.05M | 1.98% | 16 |
|
|
2022
Q1 | $15.1M | Buy |
240,683
+62,800
| +35% | +$3.94M | 1.73% | 22 |
|
|
2021
Q4 | $13.5M | Sell |
177,883
-129,817
| -42% | -$9.84M | 1.63% | 19 |
|
|
2021
Q3 | $34.4M | Hold |
307,700
| – | – | 3.24% | 15 |
|
|
2021
Q2 | $49.8M | Hold |
307,700
| – | – | 3.74% | 14 |
|
|
2021
Q1 | $37.5M | Sell |
307,700
-47,500
| -13% | -$5.79M | 1.45% | 14 |
|
|
2020
Q4 | $54.4M | Sell |
355,200
-113,000
| -24% | -$17.3M | 2.38% | 13 |
|
|
2020
Q3 | $39.2M | Hold |
468,200
| – | – | 2.04% | 15 |
|
|
2020
Q2 | $34.4M | Hold |
468,200
| – | – | 3.42% | 14 |
|
|
2020
Q1 | $19.9M | Buy |
468,200
+196,500
| +72% | +$8.33M | 2.06% | 12 |
|
|
2019
Q4 | $16.5M | Hold |
271,700
| – | – | 1.93% | 13 |
|
|
2019
Q3 | $11.1M | Hold |
271,700
| – | – | 0.61% | 12 |
|
|
2019
Q2 | $12.8M | Hold |
271,700
| – | – | 1.04% | 9 |
|
|
2019
Q1 | $9.71M | Hold |
271,700
| – | – | 0.87% | 10 |
|
|
2018
Q4 | $7.76M | Hold |
271,700
| – | – | 0.73% | 13 |
|
|
2018
Q3 | $12.1M | Buy |
+271,700
| New | +$12.1M | 1.07% | 13 |
|